We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot). You can revoke your voluntary consent at any time. You can find further information and setting options under „Configure“ and in our data protection information.
Stockholm, Sweden, May 5, 2011
Elekta has strengthened its long term loan financing by entering into a private placement agreement with U.S. institutional investors. The transaction amount is USD 200 million with tenors between seven and twelve years. Bank of America Merrill Lynch has been the placement agent in the transaction.
"The response from investors exceeded our expectations and it shows how well Elekta is perceived in the financial community. We did a private placement in 2005 of 125 million US dollar and with this additional private placement Elekta has secured a well structured long term financing", says Tomas Puusepp, President and CEO of Elekta.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.